Munshi NC - Search Results

1

Idecabtagene vicleucel for relapsed and refractory multiple myeloma: post hoc 18-month follow-up of a phase 1 trial.

Lin Y, Raje NS, Berdeja JG, Siegel DS, Jagannath S, Madduri D, Liedtke M, Rosenblatt J, Maus MV, Massaro M, Petrocca F, Yeri A, Finney O, Caia A, Yang Z, Martin N, Campbell TB, Rytlewski J, Fuller J, Hege K, Munshi NC, Kochenderfer JN. Lin Y, et al. Among authors: munshi nc. Nat Med. 2023 Sep;29(9):2286-2294. doi: 10.1038/s41591-023-02496-0. Epub 2023 Aug 17. Nat Med. 2023. PMID: 37592106 Free PMC article. Clinical Trial.

2

Biology and therapy of multiple myeloma in 1996.

Barlogie B, Jagannath S, Epstein J, Munshi N, Siegel D, Desikan KR, Feinman R, Hsu PL, von Bremen K, Tricot G. Barlogie B, et al. Semin Hematol. 1997 Jan;34(1 Suppl 1):67-72. Semin Hematol. 1997. PMID: 9122748 Review.

3

Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation.

Zent CS, Wilson CS, Tricot G, Jagannath S, Siegel D, Desikan KR, Munshi N, Bracy D, Barlogie B, Butch AW. Zent CS, et al. Blood. 1998 May 1;91(9):3518-23. Blood. 1998. PMID: 9558413 Free article.

4

Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma.

Raje N, Kumar S, Hideshima T, Ishitsuka K, Chauhan D, Mitsiades C, Podar K, Le Gouill S, Richardson P, Munshi NC, Stirling DI, Antin JH, Anderson KC. Raje N, et al. Among authors: munshi nc. Blood. 2004 Dec 15;104(13):4188-93. doi: 10.1182/blood-2004-06-2281. Epub 2004 Aug 19. Blood. 2004. PMID: 15319277 Free article.

5

p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells.

Hideshima T, Podar K, Chauhan D, Ishitsuka K, Mitsiades C, Tai YT, Hamasaki M, Raje N, Hideshima H, Schreiner G, Nguyen AN, Navas T, Munshi NC, Richardson PG, Higgins LS, Anderson KC. Hideshima T, et al. Among authors: munshi nc. Oncogene. 2004 Nov 18;23(54):8766-76. doi: 10.1038/sj.onc.1208118. Oncogene. 2004. PMID: 15480425

6

Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma.

Raje N, Kumar S, Hideshima T, Roccaro A, Ishitsuka K, Yasui H, Shiraishi N, Chauhan D, Munshi NC, Green SR, Anderson KC. Raje N, et al. Among authors: munshi nc. Blood. 2005 Aug 1;106(3):1042-7. doi: 10.1182/blood-2005-01-0320. Epub 2005 Apr 12. Blood. 2005. PMID: 15827128 Free PMC article.

7

Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma.

Neelapu SS, Munshi NC, Jagannath S, Watson TM, Pennington R, Reynolds C, Barlogie B, Kwak LW. Neelapu SS, et al. Among authors: munshi nc. Bone Marrow Transplant. 2005 Aug;36(4):315-23. doi: 10.1038/sj.bmt.1705057. Bone Marrow Transplant. 2005. PMID: 15968284 Clinical Trial.

8

FQPD, a novel immunomodulatory drug, has significant in vitro activity in multiple myeloma.

Kumar S, Raje N, Hideshima T, Ishitsuka K, Podar K, Le Gouille S, Chauhan D, Richardson P, Munshi NC, Anderson K. Kumar S, et al. Among authors: munshi nc. Br J Haematol. 2006 Mar;132(6):698-704. doi: 10.1111/j.1365-2141.2005.05946.x. Br J Haematol. 2006. PMID: 16487170 Free article.

9

In vivo and in vitro cytotoxicity of R-etodolac with dexamethasone in glucocorticoid-resistant multiple myeloma cells.

Neri P, Yasui H, Hideshima T, Tassone P, Raje N, Catley LP, Ishitsuka K, Blotta S, Kiziltepe T, Ocio EM, Fulciniti M, Kanekal S, Elliott GT, Munshi NC, Anderson KC. Neri P, et al. Among authors: munshi nc. Br J Haematol. 2006 Jul;134(1):37-44. doi: 10.1111/j.1365-2141.2006.06122.x. Br J Haematol. 2006. PMID: 16803565 Free article.

10

Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.

Tai YT, Li XF, Breitkreutz I, Song W, Neri P, Catley L, Podar K, Hideshima T, Chauhan D, Raje N, Schlossman R, Richardson P, Munshi NC, Anderson KC. Tai YT, et al. Among authors: munshi nc. Cancer Res. 2006 Jul 1;66(13):6675-82. doi: 10.1158/0008-5472.CAN-06-0190. Cancer Res. 2006. PMID: 16818641 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

432 results

Search Page